- Report
- March 2025
- 50 Pages
United Kingdom
From €545EUR$600USD£469GBP
- Report
- March 2025
- 50 Pages
Germany
From €545EUR$600USD£469GBP
- Report
- March 2025
- 50 Pages
France
From €545EUR$600USD£469GBP
- Report
- March 2025
- 50 Pages
Mexico
From €545EUR$600USD£469GBP
- Report
- March 2025
- 50 Pages
Canada
From €545EUR$600USD£469GBP
- Report
- March 2025
- 50 Pages
United States
From €545EUR$600USD£469GBP
- Report
- February 2025
- 236 Pages
United States
From €7265EUR$7,995USD£6,245GBP
- Report
- September 2024
- 117 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- June 2024
Global
From €4498EUR$4,950USD£3,866GBP
- Report
- February 2024
- 158 Pages
Global
From €4225EUR$4,650USD£3,632GBP
- Report
- November 2023
- 130 Pages
Global
From €1772EUR$1,950USD£1,523GBP
- Report
- August 2023
- 336 Pages
Global
From €4225EUR$4,650USD£3,632GBP
- Report
- August 2023
- 1300 Pages
Global
From €8087EUR$8,900USD£6,952GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4452EUR$4,900USD£3,827GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4452EUR$4,900USD£3,827GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4452EUR$4,900USD£3,827GBP
- Report
- August 2023
- 300 Pages
Europe
From €4452EUR$4,900USD£3,827GBP
- Report
- August 2023
- 51 Pages
South Korea
From €545EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
India
From €545EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Mexico
From €545EUR$600USD£469GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more